New Horizon Capital
China’s Huakang Mobile Healthcare raises $32m from VCs
Yunfeng Capital, Shenzhen Cowin Capital, New Horizon Capital and Hunan Haijie Healthcare Investment have provided RMB200 million ($32 million) in Series B funding for Huakang Mobile Healthcare, a Chinese mobile healthcare app developer.
CMC, New Horizon lead $60m round for China education site
CMC Capital Partners and New Horizon Capital have co-led a $60 million Series D round of funding for Yuantiku, valuing the Chinese online education platform at $360 million.
Capital Today, New Horizon lead $100m round for Beibei
Capital Today and New Horizon Capital have led a $100 million Series C round for Beibei.com, a Chinese online discount retail platform for maternity and baby products. Existing investors Banyan Capital and IDG Capital Partners also participated.
China pork giant WH Group gains 10.6% on HK debut
Shares in WH Group, the Chinese pork producer backed by investors such as CDH Investments and Goldman Sachs, gained as much as 10.6% on its first day trading today after the company raised HK$15.3 billion ($2 billion) on its second attempted IPO.
China's JinkoSolar raises $225m from PE investors
China Development Bank International (CDBI), New Horizon Capital and Macquarie Infrastructure and Real Assets - via the Macquarie Greater China Infrastructure Fund (MGCIF) - have invested $225 million in the downstream solar power project subsidiary of...
WH Group sets terms for HK IPO to raise $2b
WH Group, the Chinese pork producer backed by investors such as CDH Investments and Goldman Sachs, has set terms for a revised Hong Kong IPO that will raise up to HK$15.9 billion ($2.05 billion).
Investors eye liquidity as WH Group revives HK IPO
Private equity-backed Chinese pork processor WH Group is once again seeking to list in Hong Kong, three months after a HK$41 billion ($5.3 billion) IPO was scrapped.
Partial exit for PE investors as Luye Pharma raises $764m
CDH Investments, CITIC Private Equity, New Horizon Capital and GIC Private have made partial exits from Luye Pharma Group as the Chinese drug maker raised HK$5.91 billion ($764 million) through its Hong Kong IPO.
Profile: New Horizon Capital's Yasushi Ando
New Horizon Capital CEO Yasushi Ando has emerged as a leading voice for boosting the profile of private equity in Japan. His efforts are starting gain traction but the journey has not been smooth
PE-backed WH Group scraps HK IPO plan
WH Group, the PE-backed Chinese meat processing company that bought US pork producer Smithfield Foods, has abandoned its HK$41 billion ($5.3 billion) Hong Kong IPO.
PE-backed WH Group to scale back Hong Kong IPO
WH Group, the PE-backed Chinese meat processing company that acquired US pork producer Smithfield Foods, is set to reduce the size of its Hong Kong IPO size and delay pricing of the deal.
New Horizon leads $70m Series C for Arrail Dental
New Horizon Capital has led a $70 million Series C round of funding for Arrail Dental Clinic, a Beijing-based dental service provider.
VC-backed Chukong files for US IPO
Chukong Holdings, a Chinese mobile game developer backed by several VC investors, is planning to raise up to $150 million through a US IPO.
PE-backed WH Group targets $5.3b in HK IPO
WH Group, the PE-backed Chinese meat processing company that acquired US pork producer Smithfield Foods, is planning to raise as much as HK$41 billion ($5.3 billion) through a Hong Kong IPO.
PE-backed Luye, Rundong target HK IPOs – report
Two private equity-backed Chinese companies – Rundong Automobile Group and Luye Pharma Group – are reportedly planning to raise a total of $1.5 billion through Hong Kong listings.
PE investors rue lost Japan carve-out opportunities
The lack of corporate carve-outs relative to the size of the opportunity in the space has been among the biggest disappointments for Japanese private equity, investors say.
PE-backed Shuanghui eyes $6b HK IPO - report
Shuanghui International Holdings, the PE-backed Chinese meat processing company which recently acquired US pork producer Smithfield Foods, has reportedly hired six banks as sponsors for its intended $6 billion Hong Kong IPO next year.
Shareholders approve Shuanghui's $4.7b acquisition of Smithfield Foods
Shareholders of US pork producer Smithfield Foods have approved the company's $4.7 billion acquisition by its PE-backed Chinese counterpart Shuanghui International.
CFIUS approves Shuanghui acquisition of Smithfield Foods
The Committee on Foreign Investment in the United States (CFIUS) has cleared the way for PE-backed Chinese pork producer Shuanghui International to buy US counterpart Smithfield Foods, overcoming one of the biggest hurdles to the $4.7 billion deal.
Shuanghui plans HK IPO after Smithfield deal - report
China’s Shuanghui International - which is backed by CDH Investments and Goldman Sachs - intends to list US pork producer Smithfield Foods on the Hong Kong stock exchange following its planned takeover.
China.com to sell LP stake in New Horizon fund to AlpInvest
China.com, a news agency listed on Hong Kong Growth Enterprise Market (GEM) board, will sell its entire stake in New Horizon Capital IV to AlpInvest Partners for $516,000.
Banks put up $7b for PE-backed Shuanghui’s Smithfield deal – report
Bank of China and Morgan Stanley will provide $7 billion in financing for PE-backed Shuanghui International’s buyout of a US pork producer Smithfield Foods. The proposed deal, which values Smithfield at $7.1 billion including debt.
CDH, Goldman-backed Chinese pork producer bids for Smithfield
Shuanghui International, a Chinese pork producer that counts CDH Investments and Goldman Sachs among its investors, has offered $4.7 billion in cash for US-based Smithfield Foods. The proposed deal, which values Smithfield at $7.1 billion including debt,...
China GP differentiation: Plain vanilla no more
Independent funds have dominated Chinese private equity, but now princeling and affiliate funds have entered the market, offering their own competitive edge. GPs are realizing the merits of differentiation